Original Article

You have full text access to this OnlineOpen article

Gene therapy for α-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene

  1. F Kanai,
  2. Y Shiratori,
  3. Y Yoshida,
  4. H Wakimoto,
  5. H Hamada,
  6. Y Kanegae,
  7. I Saito,
  8. H Nakabayashi,
  9. T Tamaoki,
  10. T Tanaka,
  11. K Lan,
  12. N Kato,
  13. S Shiina,
  14. M Omata

Article first published online: 30 DEC 2003

DOI: 10.1002/hep.510230611

Issue

Hepatology

Hepatology

Volume 23, Issue 6, pages 1359–1368, June 1996

Additional Information

How to Cite

Kanai, F., Shiratori, Y., Yoshida, Y., Wakimoto, H., Hamada, H., Kanegae, Y., Saito, I., Nakabayashi, H., Tamaoki, T., Tanaka, T., Lan, K., Kato, N., Shiina, S. and Omata, M. (1996), Gene therapy for α-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Hepatology, 23: 1359–1368. doi: 10.1002/hep.510230611

Author Information

  1. Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan

Publication History

  1. Issue published online: 30 DEC 2003
  2. Article first published online: 30 DEC 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (422K)

References

  • 1
    Levin B, Amos C. Therapy of unresectable hepatocellular carcinoma. N Engl J Med 1995; 332: 1294–1296.
  • 2
    Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332: 1256–1261.
  • 3
    Farmer DG, Busuttil RW. The role of multimodal therapy in the treatment of hepatocellular carcinoma. Cancer 1994; 73: 2669–2670.
    Direct Link:
  • 4
    Colombo M. Hepatocellular carcinoma. J Hepatology 1992; 15: 225–236.
  • 5
    Venook AP. Treatment of hepatocellular carcinoma: too many options? J Clin Oncol 1994; 12: 1323–1334.
  • 6
    Gore ME, Collins MK. Gene therapy for cancer. Eur J Cancer 1994; 30A: 1047–1049.
  • 7
    Anderson WF. Gene therapy for cancer. Hum Gene Ther 1994; 5: 1–2.
  • 8
    Gutierrez AA, Lemoine NR, Sikora K. Gene therapy for cancer. Lancet 1992; 339: 715–721.
  • 9
    Abelev GI. Alpha-fetoprotein in oncogenesis and its association with malignant tumors. Adv Cancer Res 1971; 14: 295–358.
  • 10
    Nakabayashi H, Watanabe K, Saito A, Otsuru A, Sawadaishi K, Tamaoki T. Transcriptional regulation of α-fetoprotein expression by dexamethasone in human hepatoma cells. J Biol Chem 1989; 264: 266–271.
  • 11
    Sawadaishi K, Morinaga T, Tamaoki T. Interaction of a hepatoma-specific nuclear factor with transcription-regulatory sequences of the human α-fetoprotein and albumin genes. Mo. Cell Biol 1988; 8: 5179–5187.
  • 12
    Watanabe K, Saito A, Tamaoki T. Cell-specific enhancer activity in a far upstream region of the human α-fetoprotein gene. J Biol Chem 1987; 262: 4812–4818.
  • 13
    Nakabayashi H, Hashimoto T, Miyao Y, Tjong K-K, Chan J, Tamaoki T. A position-dependent silencer plays a major role in repressing α-fetoprotein expression in human hepatoma. Mo. Cell Biol 1991; 11: 5885–5893.
  • 14
    Nakata K, Motomura M, Nakabayashi H, Ido A, Tamaoki T. A possible mechanism of inverse developmental regulation of α-fetoprotein and albumin genes. J Biol Chem 1992; 267: 1331–1334.
  • 15
    Moolten FL. Tumor chemosensitivity conferred by inserted herpes simplex thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276–5281.
  • 16
    Moolten FL, Wells JM. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 1990; 82: 297–300.
  • 17
    Moolten FL. Drug sensitivity („suicide”) genes for selective cancer chemotherapy. Cancer Gene Therapy 1994; 1: 279–287.
  • 18
    Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN. The “bystander effect”: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274–5283.
  • 19
    Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukay-ama M, Stier LE, Pääkkö PK, et al. Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo. Science 1991; 252: 431–434.
  • 20
    Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143–155.
  • 21
    Zabner J, Couture LA, Grerory RJ, Graham SM, Smith AE, Welsh MJ. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993; 75: 207–216.
  • 22
    Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, Cartaud J, et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 1993; 361: 647–650.
  • 23
    Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ. A model system for in vivo gene transfer into the central nervous system using an adenovirus vector. Nat Genet 1993; 3: 219–222.
  • 24
    Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, et al. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter. Cancer Res 1995; 55: 3105–3109.
  • 25
    Vile RG, Hart IR. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res 1993; 53: 3860–3864.
  • 26
    Osaki T, Tanio Y, Tachibana I, Hosoe S, Kumagai T, Kawase I, Oikawa S, et al. Gene therapy for carcinoembryonic antigenproducing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 1994; 54: 5258–5261.
  • 27
    Huber BE, Richards CA, Krenitsky TA. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci U S A 1991; 88: 8039–8043.
  • 28
    Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mo. Cell Biol 1982; 2: 1044–1051.
  • 29
    Kalderon D, Roberts BL, Richardson WD, Smith AE. A short amino acid sequence able to specify nuclear location. Cell 1984; 39: 499–509.
  • 30
    Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing full-length virus genome. Proc Natl Acad Sci U S A 1996; 93: 1320–1324.
  • 31
    Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S, et al. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucl Acids Res 1996; 23: 3816–3821.
  • 32
    Nakamura Y, Wakimoto H, Abe J, Kanegae Y, Saito I, Aoyagi M, Hirakawa K, et al. Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2. Cancer Res 1994; 54: 5757–5760.
  • 33
    Niwa H, Yamamura K-I, Miyazaki J-I. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193–200.
  • 34
    Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988; 48: 589–601.
  • 35
    Nakabayashi H, Taketa K, Yamane T, Oda M, Sato J. Hormonal control of a-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium. Cancer Res 1985; 45: 6379–6383.
  • 36
    Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550–1552.
  • 37
    Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993; 53: 83–88.
  • 38
    Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann J-L, Klatzmann D. Regression of established microscopic liver metastasis after in situ transduction of a suicide gene. Proc Natl Acad Sci U S A 1993; 90: 7024–7028.
  • 39
    Li Q, Kay MA, Finegold M, Stratford-Perricaudet LD, Woo SLC. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 1993; 4: 403–409.
  • 40
    Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, et al. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci U S A 1994; 91: 2353–2357.
  • 41
    Smythe WR, Hwang HC, Amin KM, Eck SL, Davidson BL, Wilson JM, Kaiser LR, et al. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 1994; 54: 2055–2059.
  • 42
    Qian C, Bilbao R, Bruna O, Prieto J. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Hepatology 1995; 22: 118–123.
  • 43
    Macri P, Gordon JW. Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an α-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir. Hum Gene Ther 1994; 5: 175–182.
  • 44
    Paul S, Dummer S. Topics in clinical pharmacology: ganciclovir. Am J Med Sci 1992; 304: 272–277.
  • 45
    Wills KN, Huang WM, Harris MP, Machemer T, Maneval DC, Gregory RJ. Gene therapy for hepatocellular carcinoma: chemosensivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Therapy 1995; 2: 191–197.
  • 46
    Kaneko S, Hallenbeck P, Kotanni T, Nakabayashi H, McGarrity G, Tamaoki T, Anderson WF, et al. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancerspecific gene expression. Cancer Res 1995; 55: 5283–5287.
Get PDF (422K)